News

IMO Grupo Miranza, the first centre in Spain to test a gene therapy for dry AMD

SOS Visión: ophthalmology for the most vulnerable groups

The DNA is key to diagnosing inherited eye diseases

Recovery of nearly 30% of vision lost due to ocular trauma

The MiranzaCentres’excellence is endorsed by the most demanding quality seals

We present the first study on eye health during a pandemic

IMO Grupo Miranza makes the leap to Madrid

Patients with chronic eye disorders suffer the most from pandemic

World Glaucoma Week: making a silent disease heard